While FABP4 has not been studied in the context of reovirus-induced arthritis or tenosynovitis, it has been described as a biomarker of human knee osteoarthritis, where patients exhibited significantly higher systemic and synovial FABP4 [65]. Here, FABP4 is linked to arthritic joint disease.